Status:
COMPLETED
AI Augmented Training for Skin Specialists
Lead Sponsor:
Herlev Hospital
Conditions:
Melanoma
Skin Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: The worldwide incidence of skin cancer has been rising for 50 years, in particular the incidence of malignant melanoma has increased approx. 2-7% annually and is the most common cancer am...
Detailed Description
Design: This study is a superiority trial designed as an international multicenter randomized controlled trial of doctors in highly specialized centers that diagnose and/or treat skin- and mole cance...
Eligibility Criteria
Inclusion
- Doctors are required to work at a specialized skin department (dermatology or plastic surgery or the like).
- Doctors must be registered authorized health personnel
Exclusion
- Doctors that have previously received access to the DermLoop Learn educational intervention
- Doctors with less than 2 months left of their affiliation with their current department of employment
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04758988
Start Date
September 15 2021
End Date
April 30 2024
Last Update
October 16 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital
Copenhagen, Denmark, 2730
2
Gentofte Hospital
Copenhagen, Denmark, 2900